Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/MAC25) is linked to endothelial-dependent vasodilation in high-ferritin type 2 diabetes

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1615-1617

  López Bermejo, Abel ^a   Khosravi, Javad ^b   Ricart, Wifredo ^a   Castro, Antoni ^a   Hwa, Vivian ^c   Pratt, Katherine L ^c   Casamitjana, Roser ^d   Rosenfeld, Ron G ^c,e   Fernández Real, José Manuel ^a  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b Diagnostic Systems Laboratories   (Canada)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d HOSPITAL CLÍNIC   (Spain)

^e LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; FERRITIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN RELATED PROTEIN 1; TRANSFERRIN; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; HUMAN; HYPEREMIA; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; IRON DEPLETION; LABORATORY TEST; MALE; METABOLIC PARAMETERS; NON INSULIN DEPENDENT DIABETES MELLITUS; PHLEBOTOMY; SERUM; VASODILATATION;

DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; FERRITINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; IRON; MALE; MIDDLE AGED;

EID: 34249870595     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1905     Document Type: Article

References (23)

1. Feener EP, King GL: Vascular dysfunction in diabetes mellitus. Lancet 350 (Suppl. 1):SI9-SI13, 1997
2. Schalkwijk CG, Stehouwer CD: Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 109:143-159, 2005
3. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Lopez-Bermejo A, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. Diabetes Care 25:2249-2255, 2002
4. Pieper GM, Siebeneich W: Diabetes-induced endothelial dysfunction is prevented by long-term treatment with the modified iron chelator, hydroxyethyl starch conjugated-deferoxamine. J Cardiovasc Pharmacol 30:734-738, 1997
5. Nitenberg A, Paycha F, Ledoux S, Sachs R, Attali JR, Valensi P: Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors. Circulation 97:736-743, 1998
6. Ono Y, Hashimoto T, Umeda F, Masakado M, Yamauchi T, Mizushima S, Isaji M, Nawata H: Expression of prostacyclin-stimulating factor, a novel protein, in tissues of Wistar rats and in cultured cells. Biochem Biophys Res Commun 202:1490-1496, 1994
7. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H: Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J 303:591-598, 1994
8. Swisshelm K, Ryan K, Tsuchiya K, Sager R: Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc Natl Acad Sci U S A 92:4472-4476, 1995
9. Sprenger CC, Damon SE, Hwa V, Rosenfeld RG, Plymate SR: Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res 59:2370-2375, 1999
10. Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK: Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 41:1515-1527, 2005
11. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science 289:1197-1202, 2000
12. Akaogi K, Okabe Y, Sato J, Nagashima Y, Yasumitsu H, Sugahara K, Miyazaki K: Specific accumulation of tumor-derived adhesion factor in tumor blood vessels and in capillary tube-like structures of cultured vascular endothelial cells. Proc Natl Acad Sci U S A 93:8384-8389, 1996
13. Lopez-Bermejo A, Khosravi J, Corless CL, Krishna RG, Diamandi A, Bodani U, Kofoed EM, Graham DL, Hwa V, Rosenfeld RG: Generation of anti-insulin-like growth factor-binding protein-related protein 1 (IGFBP-rP1/MAC25) monoclonal antibodies and immunoassay: quantification of IGFBP-rP1 in human serum and distribution in human fluids and tissues. J Clin Endocrinol Metab 88:3401-3408, 2003
14. Hata Y, Clermont A, Yamauchi T, Pierce EA, Suzuma I, Kagokawa H, Yoshikawa H, Robinson GS, Ishibashi T, Hashimoto T, Umeda F, Bursell SE, Aiello LP: Retinal expression, regulation, and functional bioactivity of prostacyclin-stimulating factor. J Clin Invest 106:541-550, 2000
15. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W: Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes 51:1000-1004, 2002
16. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Lloyd JK, Deanfield JE: Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 340:1111-1115, 1992
17. Lopez-Bermejo A, Khosravi J, Fernandez-Real JM, Hwa V, Pratt KL, Casamitjana R, Garcia-Gil MM, Rosenfeld RG, Ricart W: Insulin resistance is associated with increased serum concentration of IGFbinding protein-related protein 1 (IGFBPrP1/MAC25). Diabetes 55:2333-2339, 2006
18. Gow AJ, Luchsinger BP, Pawloski JR, Singel DJ, Stamler JS: The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A 96:9027-9032, 1999
19. Rother RP, Bell L, Hillmen P, Gladwin MT: The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653-1662, 2005
20. Faivre-Fiorina B, Caron A, Fassot C, Fries I, Menu P, Labrude P, Vigneron C: Presence of hemoglobin inside aortic endothelial cells after cell-free hemoglobin administration in guinea pigs. Am J Physiol 276:H766-H770, 1999
21. Kim-Shapiro DB, Schechter AN, Gladwin MT: Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterioscler Thromb Vasc Biol 26:697-705, 2006
22. Natali A, Toschi E, Baldeweg S, Casolaro A, Baldi S, Sironi AM, Yudkin JS, Ferrannini E: Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels. Eur Heart J 26:464-471, 2005
23. Madsen PL, Scheuermann Freestone M, Neubauer S, Channon K, Clarke K: Haemoglobin and flow-mediated vasodilation. Clin Sci (Lond) 110:467-473, 2006